Loading market data...
Tuesday, June 30, 2026
Back to HomeKorea StockPremium

Samsung Life (032830.KS) Q1 2026: ₩18T Capital Surge as Profit Jumps 89%

By MinJeKim6 views
Share
Samsung Life (032830.KS) Q1 2026: ₩18T Capital Surge as Profit Jumps 89%

Samsung Life (032830.KS) Q1 2026: ₩18T Capital Surge as Profit Jumps 89%

A bond-revaluation tailwind lifted equity by nearly a third in a single quarter, even as core insurance margins held steady.

Source: Quarterly Report (71st FY, Q1) — Filed 15 May 2026 with DART | Consolidated Financial Statements | Unit: ₩ billions

Samsung Life Insurance reported controlling-shareholder net income of ₩1,203.6 billion for Q1 2026, an 89.5% jump from ₩635.3 billion a year earlier. The more dramatic story, however, was not in the income statement but in equity — consolidated total equity expanded from ₩64.8 trillion to ₩83.3 trillion in just three months, an ₩18.5 trillion increase driven almost entirely by unrealised gains on FVOCI-classified bonds as Korean rates declined. The K-ICS solvency ratio climbed to 209.9%, up roughly 25 percentage points from the FY2024 level of 184.9%. With IFRS 17 and IFRS 9 now in their third year of application, this quarter offers a textbook illustration of how a large life insurer with a long-duration bond book absorbs the accounting effects of a falling-rate environment.

Unlimited Korean-market analysis, $9.99/month

Samsung Life (032830.KS) Q1 2026: ₩18T Capital Surge as Profit Jumps 89%

This article became available on May 16, 2026. Subscribe to read in full, or wait until August 14, 2026 when it becomes free.

Cancel anytime. Full refund within 7 days.

NewsFinanceMarkets

Go deeper than the headline

You just read what happened. Here's how to read what it means.

This company

Full report on Samsung Life

We read Samsung Life's latest DART filing in full — financials under K-IFRS, governance, and what it means for the stock. PDF in your inbox in 30–40 min.

$12 · one-time

Get the Samsung Life report
Every name you watch

Follow the whole market

Reading several Korean stocks a week? Get on-demand analysis on any KOSPI or KOSDAQ company, whenever you need it.

$9.99 · monthly

Subscribe

Independent journalism based on primary DART filings — not investment advice. No brokerage affiliation.